Page 229 - Vitamin D and Cancer
P. 229

216                                       F.S.G. Cheung and J.K.V. Reichardt

              74.  Huang C, Ma W, Ding M et al (1997) Direct evidence for an important role of sphingomyelinase
               in ultraviolet-induced activation of c-Jun N-terminal kinase. J Biol Chem 272(44):27753–27757
              75. Huhtakangas JA, Olivera CJ, Bishop JE et al (2004) The vitamin D receptor is present in
               caveolae-enriched plasma membranes and binds 1 alpha, 25(OH)2-vitamin D3 in vivo and
               in vitro. Mol Endocrinol 18(11):2660–2671
              76.  Hutchinson PE, Osborne JE, Lear JT et al (2000) Vitamin D receptor polymorphisms are associated
               with altered prognosis in patients with malignant melanoma. Clin Cancer Res 6(2):498–504
              77.  Ingles SA, Ross RK, Yu MC et al (1997) Association of prostate cancer risk with genetic poly-
               morphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89(2):166–170
              78. Jaken S, Yuspa SH (1988) Early signals for keratinocyte differentiation: role of Ca2 + -medi-
               ated  inositol  lipid  metabolism  in  normal  and  neoplastic  epidermal  cells.  Carcinogenesis
               9(6):1033–1038
              79. John EM, Schwartz GG, Koo J et al (2005) Sun exposure, vitamin D receptor gene polymor-
               phisms, and risk of advanced prostate cancer. Cancer Res 65(12):5470–5479
              80. Jones G (2007) Expanding role for vitamin D in chronic kidney disease: importance of blood
               25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions
               of 1alpha, 25-dihydroxyvitamin D(3). Semin Dial 20(4):316–324
              81. Jones G, Blizzard C, Riley MD et al (1999) Vitamin D levels in prepubertal children in
               Southern Tasmania: prevalence and determinants. Eur J Clin Nutr 53(10):824–829
              82. Kim MS, Fujiki R, Kitagawa H et al (2007) 1alpha, 25(OH)2D3-induced DNA methylation
               suppresses the human CYP27B1 gene. Mol Cell Endocrinol 265–266:168–173
              83.  Kim S, Shevde NK, Pike JW (2005) 1, 25-Dihydroxyvitamin D3 stimulates cyclic vitamin D
               receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation
               in intact osteoblasts. J Bone Miner Res 20(2):305–317
              84. Kim YS, MacDonald PN, Dedhar S et al (1996) Association of 1 alpha, 25-dihydroxyvita-
               min D3-occupied vitamin D receptors with cellular membrane acceptance sites. Endocrinology
               137(9):3649–3658
              85. Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular, and
               neurologic abnormalities in 830 published cases. Arch Dermatol 123(2):241–250
              86. Kricker A, Armstrong BK, English DR et al (1991) Pigmentary and cutaneous risk factors
               for non-melanocytic skin cancer–a case-control study. Int J Cancer 48(5):650–662
              87. Kricker A, Armstrong BK, Hughes AM et al (2008) Personal sun exposure and risk of non
               Hodgkin  lymphoma:  a  pooled  analysis  from  the  Interlymph  Consortium.  Int  J  Cancer
               122(1):144–154
              88. Kulms D, Schwarz T (2000) Molecular mechanisms of UV-induced apoptosis. Photodermatol
               Photoimmunol Photomed 16(5):195–201
              89. Kurokawa  R,  Yu  VC,  Naar  A  et  al  (1993)  Differential  orientations  of  the  DNA-binding
               domain  and  carboxy-terminal  dimerization  interface  regulate  binding  site  selection  by
               nuclear receptor heterodimers. Genes Dev 7(7B):1423–1435
              90. Lambert PW, Stern PH, Avioli RC et al (1982) Evidence for extrarenal production of 1 alpha,
               25-dihydroxyvitamin D in man. J Clin Invest 69(3):722–725
              91. Lee  JA,  Scotto  J  (1993)  Melanoma:  linked  temporal  and  latitude  changes  in  the  United
               States. Cancer Causes Control 4(5):413–418
              92.  Lee SK, Lorenzo JA (1999) Parathyroid hormone stimulates TRANCE and inhibits osteopro-
               tegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation
               with osteoclast-like cell formation. Endocrinology 140(8):3552–3561
              93. Lehmann B, Genehr T, Knuschke P et al (2001) UVB-induced conversion of 7-dehydrocho-
               lesterol  to  1alpha,  25-dihydroxyvitamin  D3  in  an  in  vitro  human  skin  equivalent  model.
               J Invest Dermatol 117(5):1179–1185
              94. Leong GM, Wang KS, Marton MJ et al (1998) Interaction between the retinoid X receptor
               and transcription factor IIB is ligand-dependent in vivo. J Biol Chem 273(4):2296–2305
              95. Lewin B (2004) Genes VIII. Prentice Hall, Upper Saddle River
              96. Li C, Liu Z, Wang LE et al (2008) Haplotype and genotypes of the VDR gene and cutaneous
               melanoma  risk  in  non-Hispanic  whites  in  Texas:  a  case-control  study.  Int  J  Cancer
               122(9):2077–2084
   224   225   226   227   228   229   230   231   232   233   234